4–6 Dec 2017
CERN
Europe/Zurich timezone

Session

Facilities Session 1

5 Dec 2017, 09:00
503/1-001 - Council Chamber (CERN)

503/1-001 - Council Chamber

CERN

162
Show room on map

Conveners

Facilities Session 1

  • Riccardo Raabe (Instituut voor Kern- en Stralingsfysica, K.U.Leuven)

Presentation materials

There are no materials yet.

  1. Herve Savajols (GANIL)
    05/12/2017, 09:00
    Invited

    The LINAG superconducting linear accelerator of the SPIRAL2 project in GANIL (Caen) will produce stable heavy ion beams with very high currents. Their energy ranges from from 2 to 14MeV/u. These stable ion beams will enable us to observe rare events in the fields of nuclear physics, like very heavy and superheavy elements studies, neutron deficient nuclei at the proton drip line, as well as of...

    Go to contribution page
  2. Alexander Herlert (Facility for Antiproton and Ion Research (FAIR))
    05/12/2017, 09:30
    Invited

    With the ground breaking in July 2017, the construction of FAIR, the Facility for Antiproton and Ion Research, has officially started. Besides the adaption of the existing SIS18 synchrotron for FAIR operation, the ground works for the new SIS100 synchrotron tunnel is presently pursued. FAIR will host four scientific pillars: APPA, CBM, NUSTAR and PANDA. NUSTAR comprises several experiments...

    Go to contribution page
  3. Benjamin Kay (Argonne National Laboratory)
    05/12/2017, 10:00
    Invited

    The HELIOS spectrometer was developed to study of light-ion transfer reactions in inverse kinematics, where outgoing ions are transported through a solenoidal field removing the effects of kinematic compression. It operates at ATLAS at Argonne National Laboratory where it can be used with stable beams, light radioactive ion beams produced by the in-flight technique, and fission-fragment beams...

    Go to contribution page
  4. Nicholas Philip Van Der Meulen (Paul Scherrer Institut (CH))
    05/12/2017, 10:30
    Submitted

    Terbium is a unique element, as it provides a quadruplet of radionuclides suited for diagnostics and therapy in nuclear medicine [1]. Much success has been gained from the PSI-ISOLDE collaboration, with the collection and purification of 149Tb (α-emitter, T1/2 = 4.1 h – for potential therapy), used for preclinical therapy studies [2] and PET imaging [3], and 152Tb (β+-emitter, T1/2 = 17.5 h –...

    Go to contribution page
Building timetable...